ISSN - | E-ISSN -2822-2288
Most Accessed Articles - EURASIAN JOURNAL OF MEDICAL ADVANCES

Most Accessed Articles

RESEARCH ARTICLE
1. Real World Evidence on the Availability of Anti-Nuclear Antibody (ANA) in Diagnosis of Connective Tissue Diseases; A Retropective Single Center Trial
Polat Olgun, Veli Yazısız
doi: 10.14744/ejma.2022.96268  EJMA 2022; 2 - 2 | Pages 55 - 60

CASE REPORT
2. Eplerenone (Mineralocorticoid Receptor Antagonist) Induced Bilateral Gynecomastia
Weng Chio Tam, Màrio Évora
doi: 10.14744/ejma.2022.42714  EJMA 2022; 2 - 3 | Pages 146 - 147

RESEARCH ARTICLE
3. The Frequency of Vitamin B12 Deficiency in Patients with Helicobacter Pylori Infection and the Relationship Between Helicobacter Pylori and Vitamin B12 Deficiency
Nurgül Tükel, Mehmet Aliustaoglu
doi: 10.14744/ejma.2024.40085  EJMA 2024; 4 - 2 | Pages 85 - 89

REVIEW
4. Ramsey Hunt Syndrome: A Review Article
Halil İbrahim Altıner
doi: 10.14744/ejma.2023.65265  EJMA 2023; 3 - 3 | Pages 85 - 87

5. Treatment in PFAPA Syndrome: A Review
Ayşe Aydınoğlu
doi: 10.14744/ejma.2022.47965  EJMA 2023; 3 - 1 | Pages 5 - 9

CASE REPORT
6. Ribociclib-Induced Acute Pancreatitis in Metastatic Breast Cancer
Muzaffer Uğraklı, Melek Karakurt Eryılmaz, Mehmet Asıl, Ülkü Kerimoğlu, Engin Hendem, Muhammed Muhiddin Er, Mustafa Karaağaç, Murat Araz, Mehmet Artac
doi: 10.14744/ejma.2022.69188  EJMA 2022; 2 - 3 | Pages 148 - 153

REVIEW
7. Lung Cancer Risk factors - A Review Article
Cagnur Elpen Kodaz
doi: 10.14744/ejma.2022.36036  EJMA 2022; 2 - 4 | Pages 159 - 162

8. Difficulties in the Diagnosis and Management of Fetal Growth Restriction
Barbaros Ateşli
doi: 10.14744/ejma.2023.88528  EJMA 2023; 3 - 3 | Pages 114 - 119

9. Occupational Eye Diseases
Yasemin Yurt
doi: 10.14744/ejma.2023.03521  EJMA 2023; 3 - 1 | Pages 1 - 4

RESEARCH ARTICLE
10. The Relationship Between Spot Urinary Protein/Creatinine Ratio and HbA1C, Metabolic Parameters and Other Complications in Patients with Type 2 Diabetes
Şaban Seçmeler, Emre Hoca, Hayriye Esra Ataoğlu
doi: 10.14744/ejma.2022.29392  EJMA 2022; 2 - 2 | Pages 81 - 87

REVIEW
11. Infectious Spondylodiscitis, an Overlooked Cause of Pain: A Review
Aysel Çınar Sayhan
doi: 10.14744/ejma.2022.08370  EJMA 2023; 3 - 2 | Pages 61 - 66

RESEARCH ARTICLE
12. Work-Life Balance in Nurses
Gurmeet Singh Sarla, Manreet Sandhu
doi: 10.14744/ejma.2024.55375  EJMA 2024; 4 - 4 | Pages 224 - 227

13. Impact of Diabetes on Clinical Outcomes of Prostate Cancer
Melike Özçelik, Gökhan Yaprak, Cengiz Gemici, Abdilkerim Oyman, Ibrahim Çil, Serhat Özçelik
doi: 10.14744/ejma.2022.72792  EJMA 2022; 2 - 3 | Pages 100 - 104

14. Cancer Diagnosis In Tunisian Public Structures: Too Little, Too Late
Mohamed Jemaà
doi: 10.14744/ejma.2023.96158  EJMA 2023; 3 - 4 | Pages 160 - 163

15. The Effect of Hypochlorous Acid on Preventing Postoperative Peritoneal Adhesions: An Experimental Study
Özge Öztürk, Akgun Oral, Malik Ergin
doi: 10.14744/ejma.2022.44153  EJMA 2022; 2 - 3 | Pages 111 - 117

16. Berlin-Frankfurt-Munster (BFM) versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone (Hyper-CVAD) chemotherapy regimens in Adult T-Cell ALL and Adolescent and Young Adult (AYA) Patients
Merve Özkan, Şerife Solmaz, Ahmet Seyhanlı, Müjdenur Koç, Güner Hayri Özsan, Fatih Demirkan, Zeynep Yüce, Oğuz Altungöz, Inci Alacacıoğlu
doi: 10.14744/ejma.2022.70299  EJMA 2022; 2 - 2 | Pages 39 - 45

REVIEW
17. Thoracic and Abdominal Oncological Emergencies in Radiology
Marco Fogante, Matteo Marcucci, Corrado Tagliati
doi: 10.14744/ejma.2022.33043  EJMA 2022; 2 - 2 | Pages 23 - 29

RESEARCH ARTICLE
18. Protective Effects of Silymarin on Acetaminophen-Induced Toxic Hepatitis
Abdilkerim Oyman, Gulbin Unsal, Nurettin Aydogdu, Ufuk Usta
doi: 10.14744/ejma.2022.32042  EJMA 2022; 2 - 1 | Pages 1 - 6

19. Detailed Analysis of Follicular Lymphoma over 25 Years: A Single-Center, Retrospective Study
Hasan Cagri Yildirim, Fatos Dilan Atilla, Fahri Sahin, Guray Saydam, Filiz Vural, Murat Tombuloglu, Mahmut Tobu
doi: 10.14744/ejma.2022.35220  EJMA 2022; 2 - 1 | Pages 7 - 12

REVIEW
20. Navigating Neurologic Adverse Events in Immune Checkpoint Inhibitor Therapy: Challenges and Strategies
Arzu Aldemir Atmaca
doi: 10.14744/ejma.2023.94830  EJMA 2023; 3 - 3 | Pages 88 - 104